摘要
目的 探讨舒肝颗粒治疗脑梗死后抑郁症(PSD)的疗效及对脑源性神经营养因子(BDNF)和炎症因子水平的影响。方法 160例PSD患者随机分为对照组和研究组,每组80例。对照组在常规治疗基础上给予氢溴酸西酞普兰,20 mg·d-1口服;研究组在对照组的基础上给予舒肝颗粒,每次3 g(1袋),2 次·d-1,温水冲服。8周为1个疗程。比较两组患者的临床疗效;HAMD评分;BI指数,BDNF以及炎症因子水平的差异。结果 研究组临床总有效率88.75%显著高于对照组76.25%,差异有统计学意义(χ2=4.329,P<0.05)。重复测量资料方差分析结果显示,研究组HAMD评分整体水平显著低于对照组(F组间=36.541,P<0.05),两组患者HAMD评分均随治疗时间延长而降低(F时间=668.574,P<0.05),研究组HAMD评分降低幅度显著大于对照组(F交互=18.495,P<0.05)。研究组BI指数和BDNF整体水平显著高于对照组(F组间分别为48.147,41.561,P<0.05),两组患者BI指数和BDNF水平均随治疗时间延长而升高(F时间分别为316.586,595.864,P<0.05),研究组BI指数和BDNF水平升高幅度显著高于对照组(F交互=22.849,10.515,P<0.05)。研究组TNF-α,IL-6以及hs-CRP整体水平显著低于对照组(F组间分别为117.849,85.168,66.763,P<0.05),两组患者TNF-α,IL-6以及hs-CRP水平均随治疗时间延长而降低(F时间分别为864.584,697.717,1 037.167,P<0.05),研究组TNF-α,IL-6以及hs-CRP水平降低幅度显著大于对照组(F交互分别为31.271,26.174,17.585,P<0.05)。两组患者不良反应无显著性差异(11.25%与18.75%,χ2=1.765,P>0.05)。结论 在常规西药治疗的基础上加用舒肝颗粒,能够更好的改善PSD患者的抑郁程度,降低炎症因子水平。
Abstract
OBJECTIVE To investigate the curative effect of Shugan granule in the treatment of post-stroke depression (PSD) and effect on brain devived neurotrophic factor(BDNF) and inflammatory factors.METHODS Eighty Patients with PSD were randomly divided into control group and study group, 80 cases in each group. Besides routine treatment, control group received citalopram hydrobromide 20 mg·d-1. Study group received Shugan granule 1 bags·time-1, twice a day based on control group.8 weeks for a course of treatment. HAMD scores, BI index, BDNF and inflammatory factors levels were compared.RESULTS The total effective rate in study group was significantly higher than that in control group[71 cases,88.75% vs 61 cases, 76.25%, χ2=4.329, P<0.05]. Repeated measurement data analysis of variance showed, the overall scores of HAMD in study group were significantly lower than those in control group [Fgroup=36.541, P<0.05]. The HAMD scores of the two groups decreased with the extension of treatment time [Ftime=668.574, P<0.05].The reduction extent of HAMD score in study group was significantly higher than that in control group[Fgroup×time=18.495, P<0.05]. BI indexes and BDNF levels in study group were significantly higher than those in control group [Fgroup=48.147, 41.561, P<0.05]. BI indexes and BDNF levels of two groups increased with the extension of treatment time [Ftime=316.586, 595.864, P<0.05]. The increasing extent of BI indexes and BDNF levels in study group was significantly higher than that in control group [Fgroup×time=22.849, 10.515, P<0.05]. The overall levels of TNF-α, IL-6 and hs-CRP in study group were significantly lower than those in control group [Fgroup=117.849, 85.168, 66.763, P<0.05]. TNF-α, IL-6 and hs-CRP levels of two groups decreased with the extension of treatment time [Ftime=864.584, 697.717, 1 037.167, P<0.05]. The reduction extent of TNF-α, IL-6 and hs-CRP levels in study group was significantly higher than that in control group[Fgroup×time=31.271, 26.174, 17.585, P<0.05]. There was no significant difference in adverse reactions between the two groups [9 cases, 11.25% vs 15 cases, 18.75%, χ2=1.765, P>0.05].CONCLUSION On the basis of conventional western medicine treatment, Shugan granules can improve the degree of depression and reduce the level of inflammatory factors in patients with PSD.
关键词
脑梗死后抑郁症 /
舒肝颗粒 /
脑源性神经营养因子 /
炎症因子 /
临床疗效
{{custom_keyword}} /
Key words
post-stroke depression /
shugan granule /
BDNF /
inflammatory factor /
curative effec
{{custom_keyword}} /
刘晓溪,孙海民,商萌萌,李会敏,史福平,张杏红,宋月平.
舒肝颗粒治疗脑梗死后抑郁症的疗效及对BDNF和炎症因子水平的影响[J]. 中国药学杂志, 2018, 53(13): 1140-1144 https://doi.org/10.11669/cpj.2018.13.019
LIU Xiao-xi, SUN Hai-min, SHANG Meng-meng, LI Hui-min, SHI Fu-ping, ZHANG Xing-hong, SONG Yue-ping.
The Curative Effect of Shugan Granule in the Treatment of Post-stroke Depression and Effect on BDNF and Inflammatory Factors[J]. Chinese Pharmaceutical Journal, 2018, 53(13): 1140-1144 https://doi.org/10.11669/cpj.2018.13.019
中图分类号：
R969
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] WAN Q R,HU Y R, LIU H, et al. Effects of sertraline in early prophylactic treatment on neurological rehabilitation in patients with acute cerebral infarction[J]. Chin Hosp Pharm J (中国医院药学杂志),2015,35(19):1768-1771.
[2] HU D,SHENG L. Clinical observation on efficacy of modified Chaihu Shugan Granule for treating post ischemic stroke depression[J]. Chin Tradit Herb Drugs(中草药), 2016, 47(21):3866-3870.
[3] MACINTOSH B J, EDWARDS J D, KANG M, et al. Post-stroke fatigue and depressive symptoms are differentially related to mobility and cognitive performance[J]. Front Aging Neurosci, 2017, 31;9:343. doi: 10.3389/fnagi.2017.00343.
[4] Psychiatric Association of Chinese Medical Association. Classification and diagnosis standard of mental disorders in China[S]. 3rd ed,2000.
[5] Neurological branch of Chinese Medical Association. Key points of diagnosis for various cerebrovascular diseases[J]. Chin J Neurol (中华神经科杂志), 1996, 29(6):371-379.
[6] The State Administration of traditional Chinese medicine. Diagnostic criteria for TCM syndromes[S]. 1994.
[7] Guidelines for clinical research of new Chinese medicine (Trial Implementation)[S]. 2002.
[8] Chinese Society of Traditional Chinese Medicine. Guidelines for Diagnosis and Treatment of Common Diseases in Internal Medicine of Traditional Chinese Medicine(中医内科常见病诊疗指南)[M]. Beijing: China Traditional Chinese Medicine Press, 2008:231-250.
[9] HUANG Y, XU W P, ZHANG Y L, et al. A clinical observation of Rhizoma Polygonati Combined with mirtazapine in treatment of elderly post-cerebral infarction depression[J]. Anhui Med Pharm J(安徽医药),2017,21(9):1702-1705.
[10] SUN N, LI Q J, LV D M, et al. A survey on 465 patients with post-stroke depression in China[J]. Arch Psychiatr Nurs, 2014,28(6):368-371.doi: 10.1016/j.apnu.2014.08.007.
[11] PANG J Y, GUO H R, SHI Y X, et al. Effects of Shugan Granule in treatment of anxiety disorders[J]. Neur Dis Ment Hyg(神经疾病与精神卫生),2013, 13(1):33-36.
[12] CHENG F, SHAO G F, BAO S Y, et al. Study of effect on neurologic function rehabilitation in patient with post-strok depression[J]. Chin J Clin Rehabil(中国临床康复), 2003, 7(1):108-109.
[13] GUO M,LI H L, HUANG Y L, et al. Relationship between post-stroke depression and serum cytokines[J]. Chin Ment Health J (中国心理卫生杂志), 2008, 22(2):101-104.
[14] MIAO X Q, GUO J J, WU X Y, et al. Investigation and analysis of the correlation between IL-1, IL-18, hs-CRP and post-stroke depression[J]. Shenzhen J Integr Tradit Chin West Med (深圳中西医结合杂志), 2017,27(5):3-5.
[15] NIU H L, MA L, WANG L C, et al. Expression of IL-1, IL-2, IL-6 and TNF- alpha in serum of patients with post-stroke depression and its clinical significance[J]. Mod Med J(现代医学), 2016,44(1):89-91.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
河北省重点研发计划项目资助(18277795D);河北省卫生厅指导项目资助(ZD20140041);河北大学附属医院青年科研基金项目资助(2016Q015)
{{custom_fund}}
PDF(1117 KB)
